This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (
datacentre@scilifelab.se) if you think anything looks out of place.Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000.
JSON
Golparian D, Jacobsson S, Ohnishi M, Unemo M
Microbiol Resour Announc 12 (3) e0113022 [2023-03-16; online 2023-02-28]
Zoliflodacin is a promising novel antimicrobial in clinical development for treatment of gonorrhea; currently, it is in a global phase 3 randomized controlled clinical trial. High activity against global Neisseria gonorrhoeae strains has been shown. We present the complete reference genome of the zoliflodacin-resistant strain H035, which was identified in Japan in 2000.
Clinical Genomics Örebro [Collaborative]
PubMed 36853044
DOI 10.1128/mra.01130-22
Crossref 10.1128/mra.01130-22